Adverse Drug Reaction Classification System

         

ADR Ontology
ADR Term Hepatobiliary neoplasms malignancy unspecified
ADR ID BADD_A02042
ADR Hierarchy
16      Neoplasms benign, malignant and unspecified (incl cysts and polyps)
16.07      Hepatobiliary neoplasms malignant and unspecified
16.07.03      Hepatobiliary neoplasms malignancy unspecified
Description Not Available
MedDRA Code 10019814
MeSH ID Not Available
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
Not Available
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D01818Pramipexole dihydrochloride--
BADD_D01922Regorafenib0.000224%
BADD_D01933Ribavirin0.007912%
BADD_D01938Rifaximin0.000482%
BADD_D02029Sitagliptin0.000053%
BADD_D02053Sofosbuvir0.000282%
BADD_D02058Sorafenib0.000168%
BADD_D02100Sunitinib0.000336%
BADD_D02154Tenofovir0.001939%
BADD_D02170Testosterone--
BADD_D02171Testosterone cypionate--
BADD_D02172Testosterone enanthate--
BADD_D02173Testosterone propionate--
BADD_D02174Testosterone undecanoate--
BADD_D02331Valsartan0.000185%
BADD_D02344Vemurafenib0.000112%
BADD_D02345Venetoclax0.000168%
BADD_D02375Water--
BADD_D02392Zoledronic acid--
BADD_D02393Zolmitriptan--
BADD_D02412Octreotide0.000931%
BADD_D02483Ribociclib0.000168%
BADD_D02510Rucaparib0.000112%
BADD_D02591Ripretinib0.000168%
The 2th Page    First    Pre   2    Total 2 Pages